SAN FRANCISCO, January 7, 2025 – Coval Biopharma, today announced that it is presenting at Biotech Showcase™ 2025.
Dr. Hao Zhang, Founder and CEO, will be presenting Coval Biopharma at Biotech Showcase.
Date: Monday, January 13, 2025
Time: 3:15PM
Location: Hilton San Francisco Union Square, 333 O'Farrell St, San Francisco, CA 94102
Franciscan B (Ballroom Level)
"Our MolecularX™ platform is dedicated to patient-centric product design, striving to enhance quality of life through innovative solutions", said Dr. Hao Zhang, CEO of Coval Biopharma.
Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year in San Francisco during the course of one of the industry's largest gatherings and busiest weeks.
"We are delighted that Coval Biopharma will be joining us in San Francisco and presenting at Biotech Showcase this year," said Sara Demy, CEO of Demy-Colton. "Biotech Showcase is a prime opportunity for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of human health."
ABOUT BIOTECH SHOWCASE
Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 17th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.
ABOUT COVAL BIOPHARMA
Coval Biopharma is a forward-thinking new drug product development company based in Shanghai, dedicated to transforming the treatment landscape for chronic diseases. Founded by a team of seasoned global pharma experts, Coval leverages its proprietary MolecularX™ platform, an advanced molecular assembly system, to develop innovative, locally targeted therapies. By focusing on delivering treatments at disease sites with high efficacy and low systemic exposure, we aim to address unmet medical needs and improve patients' quality of life. At Coval, we are redefining possibilities in chronic disease management through science, innovation, and a commitment to excellence.
Contacts
Email: ca_lisa@covalbiopharma.com